Literature DB >> 15799549

Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells.

Michael C Graves1, Milan Fiala, Lu Anne V Dinglasan, Nancy Q Liu, James Sayre, Francesco Chiappelli, Cees van Kooten, Harry V Vinters.   

Abstract

Recent studies have shown inflammatory markers in affected neural tissues of amyotrophic lateral sclerosis (ALS) patients. We examined immunocytochemically spinal cord tissues of six patients with ALS, two with corticospinal tract degeneration secondary to cerebral infarcts and three control subjects without neuropathologic abnormalities. ALS spinal cords had dense macrophage infiltration (one log greater than control spinal cords) involving the white and gray matter, with heaviest infiltration of lateral and ventral columns and, in one patient, prefrontal gyrus and the occipital lobes of the brain. Macrophages in ALS spinal cord showed strong expression of cyclooxygenase-2 (COX-2) (one log greater than control tissues) and inducible nitric oxide synthase. In the gray matter, macrophages surrounded and appeared to phagocytize neurons (NeuN-positive) that appeared to be dying. Vessels showed damage to the tight junction protein ZO-1 in relation to perivascular CD40 receptor-positive macrophages and CD40 ligand-positive T lymphocytes. ALS spinal cords, but not control cords, were sparsely infiltrated with mast cells. In control cases with corticospinal tract degeneration following hemispheric cerebral infarction, macrophage infiltration of the white matter was COX-2-negative and restricted to lateral and anterior corticospinal tracts. Our data suggest that inflammation in ALS spinal cord and cortex is based on innate immune responses by macrophages and mast cells and adaptive immune responses by T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15799549     DOI: 10.1080/14660820410020286

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  90 in total

1.  Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways.

Authors:  Larry Lam; Ramesh C Halder; Dennis J Montoya; Liudmilla Rubbi; Arturo Rinaldi; Bien Sagong; Sarah Weitzman; Rachel Rubattino; Ram Raj Singh; Matteo Pellegrini; Milan Fiala
Journal:  Am J Neurodegener Dis       Date:  2015-12-28

Review 2.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.

Authors:  Kristopher G Hooten; David R Beers; Weihua Zhao; Stanley H Appel
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies.

Authors:  Grant Coan; Cassie S Mitchell
Journal:  Neurodegener Dis       Date:  2015-07-16       Impact factor: 2.977

Review 4.  The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach.

Authors:  Frederick O Cope; Bonnie Abbruzzese; James Sanders; Wendy Metz; Kristyn Sturms; David Ralph; Michael Blue; Jane Zhang; Paige Bracci; Wiam Bshara; Spencer Behr; Toby Maurer; Kenneth Williams; Joshua Walker; Allison Beverly; Brooke Blay; Anirudh Damughatla; Mark Larsen; Courtney Mountain; Erin Neylon; Kaeli Parcel; Kapil Raghuraman; Kevin Ricks; Lucas Rose; Akhilesh Sivakumar; Nicholas Streck; Bryan Wang; Christopher Wasco; Larry S Schlesinger; Abul Azad; Murugesan V S Rajaram; Wael Jarjour; Nicholas Young; Thomas Rosol; Amifred Williams; Michael McGrath
Journal:  Nucl Med Biol       Date:  2015-12-03       Impact factor: 2.408

5.  Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.

Authors:  Mathew T Mizwicki; Milan Fiala; Larry Magpantay; Najib Aziz; James Sayre; Guanghao Liu; Avi Siani; Derrick Chan; Otoniel Martinez-Maza; Madhuri Chattopadhyay; Antonio La Cava
Journal:  Am J Neurodegener Dis       Date:  2012-11-21

6.  A glutamate-dependent redox system in blood cells is integral for phagocytosis in Drosophila melanogaster.

Authors:  Jessica Tang; Ashley E Nazario-Toole; Elizabeth A Gonzalez; Aprajita Garg; Louisa P Wu
Journal:  Curr Biol       Date:  2013-11-07       Impact factor: 10.834

7.  Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Savina Apolloni; Paola Fabbrizio; Chiara Parisi; Susanna Amadio; Cinzia Volonté
Journal:  Mol Neurobiol       Date:  2014-12-09       Impact factor: 5.590

Review 8.  ER stress and unfolded protein response in amyotrophic lateral sclerosis.

Authors:  Kohsuke Kanekura; Hiroaki Suzuki; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2009-01-30       Impact factor: 5.590

9.  Reduction of circulating endothelial cells in peripheral blood of ALS patients.

Authors:  Svitlana Garbuzova-Davis; Robert L Woods; Michael K Louis; Theresa A Zesiewicz; Nicole Kuzmin-Nichols; Kelly L Sullivan; Amber M Miller; Diana G Hernandez-Ontiveros; Paul R Sanberg
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

10.  IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.

Authors:  Milan Fiala; Madhuri Chattopadhay; Antonio La Cava; Eric Tse; Guanghao Liu; Elaine Lourenco; Ascia Eskin; Philip T Liu; Larry Magpantay; Stephen Tse; Michelle Mahanian; Rachel Weitzman; Jason Tong; Caroline Nguyen; Tiffany Cho; Patrick Koo; James Sayre; Otoniel Martinez-Maza; Mark J Rosenthal; Martina Wiedau-Pazos
Journal:  J Neuroinflammation       Date:  2010-11-09       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.